# Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene

> **NCT00444795** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 520 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Sunitinib malate
- **DRUG:** Sunitinib malate
- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT00444795
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444795, "Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00444795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*